Sius(TM) TFF skid to be showcased at the Disposable Solutions for Biomanufacturing tradeshow in Brussels on February 19-20, 2013.
New plant on its Mourenx, France site to produce a large volume commercial API.
Pompey, France, 2nd October 2012 - Novasep, a leading provider of purification-based manufacturing solutions for life science molecules, today announces the appointment of Roger-Marc Nicoud, founder and CEO, as Non-Executive Chairman of the Board, effective on October 1st, 2012.
Pompey, France, July 19, 2012 - Novasep, a leading supplier of manufacturing solutions to the life sciences industries, announces today a three million euro investment to expand its Highly Potent API (HPAPI) manufacturing capabilities at its Le Mans (France) facility. The expansion has been designed to allow Novasep to serve the increased demand for manufacturing of novel anti-cancer therapies.
Pompey, France, April 23, 2011 – Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group’s Corporate Quality Director and a member of Novasep’s executive committee, while Alain Lamproye joins Novasep Process, the company’s biomolecules division, as Director of Novasep Belgium and becomes a member of Novasep Process’s management committee.
Cerenis Therapeutics to present manufacturing data for this biopharmaceutical against atherosclerotic cardiovascular disease at BioProcess International (BPI) Conference in Prague (Czech Republic), April 18, 2012.
New site increases Novasep’s process development and engineering capabilities to supply turnkey purification processes in East Asia.
A strongly improved balance sheet, new shareholders and an entrepreneurial management to support the group’s development going forward.
New protein A media boosts productivity in monoclonal and polyclonal antibody capture, lowers costs.
All Novasep Synthesis sites pass FDA inspections in last three years.